MOH:NYSEMolina Healthcare Inc Analysis

Molina Healthcare (MOH) is trading at $186.18, just below its 20‑day SMA of $186.33 and with a neutral RSI of 59, while the MACD shows a bearish divergence (histogram –1.96) and volume is on a downtrend, suggesting short‑term pressure. Fundamentally, the stock trades at a trailing P/E of 49.9 versus an industry average of 27, yet a discounted cash‑flow model values it around $290, implying a potential long‑run upside despite a modest –1.8% downside relative to analyst targets. Recent Q1 results showed a 3.1% revenue decline to $10.8 bn and guidance 5.2% below consensus, but non‑GAAP EPS beat expectations by 21%, and the broader health‑insurance sector received a lift from UnitedHealth’s strong earnings. Margins remain thin (gross 8.9%, operating 1.7%) and debt‑to‑equity is high at 96.7%, but the company holds $9.3 bn in cash and generated $0.76 bn of free cash flow.
The combination of high volatility (50% 30‑day), low beta, and significant regulatory exposure creates a medium‑to‑high risk profile, while the lack of dividend eliminates income considerations. Given the DCF upside, modest analyst consensus (hold), and mixed technical signals, the stock appears fairly valued in the near term but offers upside potential for investors comfortable with regulatory and earnings volatility.